Cajal Neuroscience

United States
Seattle, Washington, United States, 98102

Company profile

Cajal Neuroscience company profile

Cajal Neuroscience is a biotechnology company integrating human genetics, functional genomics, and advanced microscopy to discover novel targets and therapeutics for neurodegeneration. The company combines a suite of state-of-the-art approaches and technologies, including integrative human genetics and multi-omics, high-throughput functional genomics, and advanced microscopy, to accelerate neurodegeneration target and drug discovery.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$1M-$10M
Founded
2020-01-01, Year

Headquarters

Postal code
98102
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$96M
Last funding
Series A / $96M / 2022-11-29
Last equity funding
Series A / $96M
Investors
7
Lead investors
2
Founders
6
Articles
15

Founders and investors

Founders

Alex VaughanAndrew DervanCharles ZukerHuda ZoghbiIan PeikonRobert Hershberg

Lead investors

Lux CapitalThe Column Group

Investors

Alexandria Venture InvestmentsBristol-Myers SquibbLux CapitalThe Column GroupTwo Sigma Ventures